Kenya ePrescription FHIR Implementation Guide
0.1.0 - ci-build
Kenya ePrescription FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "MedicationStatement",
"id" : "example-medicationstatement-amina-azithromycin",
"meta" : {
"profile" : [
🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/ke-medication-statement"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Medication Statement MEDS-2025-00234</b></p><p>Amina Hassan completed a 3-day course of Azithromycin 500 mg (15–17 June 2025), recorded at KNH outpatient consultation. Status: completed. Asserted: 18 June 2025.</p></div>"
},
"identifier" : [
{
"system" : "https://ilm-hie.dha.go.ke/fhir/NamingSystem/medstatement-identifier",
"value" : "MEDS-2025-00234"
}
],
"status" : "completed",
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/generic-products-cs",
"code" : "GE10015",
"display" : "Azithromycin 500 mg Oral Tablet"
}
]
},
"subject" : {
🔗 "reference" : "Patient/example-patient-amina"
},
"context" : {
🔗 "reference" : "Encounter/example-encounter-amina-outpatient"
},
"effectivePeriod" : {
"start" : "2025-06-15",
"end" : "2025-06-17"
},
"dateAsserted" : "2025-06-18",
"informationSource" : {
🔗 "reference" : "Patient/example-patient-amina"
},
"note" : [
{
"text" : "Patient confirmed completing the full 3-day course without missing a dose. No adverse effects reported."
}
],
"dosage" : [
{
"text" : "1 tablet (500 mg) orally once daily for 3 days",
"timing" : {
"repeat" : {
"frequency" : 1,
"period" : 1,
"periodUnit" : "d"
}
},
"route" : {
"coding" : [
{
"system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/route-of-administration-cs",
"code" : "RT10025",
"display" : "Oral"
}
]
}
}
]
}